Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

Table 2 Cumulative incidence of HCC in different patient groups stratified by IL-17 and AFP concentrations

	IL-17					AFP
	Cutoff	Cumulative incidence at year				Cutoff	Cumulative incidence at year
	(pg/ml)	1	2	3	4	(ng/ml)	1	2	3	4
< Median	< 455	0.000	0.035	0.045	0.050	< 3.9	0.000	0.025	0.035	0.045
≥ Median	≥ 455	0.059	0.079	0.113	0.126	≥ 3.9	0.059	0.089	0.123	0.128
Tertile 1	< 140	0.000	0.015	0.022	0.022	< 3	0.000	0.029	0.037	0.051
Tertile 2	< 1105	0.015	0.067	0.096	0.111	< 4.9	0.015	0.037	0.059	0.059
Tertile 3	≥ 1105	0.076	0.089	0.119	0.126	≥ 4.9	0.076	0.106	0.144	0.152
Quartile 1	< 20	0.000	0.020	0.029	0.029	< 2.7	0.000	0.020	0.030	0.050
Quartile 2	< 455	0.000	0.051	0.061	0.071	< 3.9	0.000	0.030	0.040	0.040
Quartile 3	< 1850	0.029	0.069	0.098	0.108	< 6	0.029	0.049	0.078	0.078
Quartile 4	≥ 1850	0.090	0.089	0.129	0.143	≥ 6	0.090	0.130	0.170	0.180

ISSN: 1471-230X